Clinical Trial Update: Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for GAIA-102 in advanced and relapse non-small cell lung cancer across Phase 1 and Phase 2 stages; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GAIA-102

Snippet

Sponsor: GAIA BioMedicine Inc. | Conditions: Cell Therapy, NSCLC | Phase 1, Phase 2 | Status: UNKNOWN